B683 (Rabeprazole Sodium Delayed-Release 20 mg)
Pill with imprint B683 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Rabeprazole is used in the treatment of barrett's esophagus; gerd; duodenal ulcer; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for B683
More about rabeprazole
- Rabeprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 58 Reviews
- Drug class: proton pump inhibitors
- FDA Alerts (3)
- Rabeprazole Delayed-Release Tablets
- Rabeprazole Sprinkle Capsules
- Rabeprazole (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.